66.72
-0.80 (-1.18%)
| Previous Close | 67.51 |
| Open | 67.00 |
| Volume | 315,816 |
| Avg. Volume (3M) | 1,273,191 |
| Market Cap | 11,574,585,344 |
| Price / Earnings (TTM) | 7.51 |
| Price / Earnings (Forward) | 11.36 |
| Price / Sales | 1.56 |
| Price / Book | 2.56 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2026 |
| Profit Margin | 4.56% |
| Operating Margin (TTM) | 7.73% |
| Diluted EPS (TTM) | 2.17 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | -42.20% |
| Total Debt/Equity (MRQ) | 242.58% |
| Current Ratio (MRQ) | 1.19 |
| Operating Cash Flow (TTM) | 772.00 M |
| Levered Free Cash Flow (TTM) | 1.05 B |
| Return on Assets (TTM) | 3.72% |
| Return on Equity (TTM) | 10.66% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Solventum Corporation | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 2.0 |
| Average | 2.38 |
|
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 20.00% |
| % Held by Institutions | 67.75% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 100.00 (BTIG, 49.89%) | Buy |
| Median | 99.00 (48.39%) | |
| Low | 83.00 (Wells Fargo, 24.41%) | Hold |
| Average | 94.00 (40.90%) | |
| Total | 2 Buy, 1 Hold | |
| Avg. Price @ Call | 74.20 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 27 Feb 2026 | 100.00 (49.89%) | Buy | 74.20 |
| Keybanc | 27 Feb 2026 | 99.00 (48.39%) | Buy | 74.20 |
| Wells Fargo | 27 Feb 2026 | 83.00 (24.41%) | Hold | 74.20 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ALBAN CARLOS | - | - | 0 | 0 |
| COX CARRIE SMITH | - | - | 0 | 0 |
| DEVORE SUSAN D. | - | - | 0 | 0 |
| EDWARDS SHIRLEY ANN | - | - | 0 | 0 |
| EISENBERG GLENN A | - | - | 0 | 0 |
| HARRIS BERNARD A JR | - | - | 0 | 0 |
| MAY KAREN J | - | - | 0 | 0 |
| MILY ELIZABETH | - | - | 0 | 0 |
| WEILAND JOHN H | - | - | 0 | 0 |
| WENDELL AMY MCBRIDE | - | - | 0 | 0 |
| WILSON DARRYL L. | - | - | 0 | 0 |
| Aggregate Net Quantity | 0 | |||
| Aggregate Net Value ($) | 0 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ALBAN CARLOS | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| COX CARRIE SMITH | Director | 30 Apr 2026 | Option execute | 4,916 | - | - |
| DEVORE SUSAN D. | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| EDWARDS SHIRLEY ANN | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| EISENBERG GLENN A | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| HARRIS BERNARD A JR | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| MAY KAREN J | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| WILSON DARRYL L. | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| MILY ELIZABETH | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| WEILAND JOHN H | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| WENDELL AMY MCBRIDE | Director | 30 Apr 2026 | Option execute | 3,403 | - | - |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |